UBS lowered the firm’s price target on ArcBest (ARCB) to $77 from $80 and keeps a Neutral rating on the shares. ArcBest repoted upside to Q3 on the cost side, but guidance for Q4 was softer due to weaker volume, the analyst tells investors in a research note.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARCB: